T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma
2019
Key points T cells from patients early in myeloma therapy exhibit better fitness for CAR T manufacturing than those from relapsed/
refractorypatients. CAR T cells may be more effective if manufactured from patients before onset of relapsed/
refractorydisease.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
13
References
43
Citations
NaN
KQI